Overview
Public Biotech
Developing GH001 (5-MeO-DMT) for treatment-resistant depression via inhalation.
Visit WebsiteDublin, Ireland
$180M
Market Cap
2018
Founded
40
Employees
0
Open Roles
Open Positions
No open positions at this time
Clinical Pipeline
No clinical trials on record